What is the optimal duration of bisphosphonate therapy?
There are currently no guidelines for long- term management of patients on denosumab, and also no data to suggest whether patients should be switched to a ...
Aetna Better Health®The NCCN Guideline for prostate cancer supports the use of Prolia as prevention or treatment of osteoporosis during androgen deprivation therapy ... The effect of 8 or 5 years of denosumab treatment in ... - FLOREFurthermore, given that osteoporosis is a chronic condition, and prolonged administration of bisphosphonates has raised concerns about rare but serious adverse ... Denosumab: Prolia®; Jubbonti®; Xgeva®; Wyost®Patients should be encouraged to continue denosumab therapy long term. If discontinuation does occur, appropriate steps must be taken to prevent the rapid bone.
Autres Cours:
